Ferrate(VI) (FeVIO42, Fe(VI)) is an emerging oxidant/disinfectant to treat a wide range of contaminants and microbial pollutants in wastewater. This study describes the inactivation of murine ...

ABSTRACT BACKGROUND: Norovirus (NoV) is an important etiologic agent of acute gastroenteritis and infects individuals of all ages, especially children in Brazil and worldwide. NoV GII.4 was the most ...

We aren't quite clear of peak norovirus season just yet, and if you come down with the debilitating virus, the symptoms could linger in your system for some time. Here's what you need to know if ...

Vaxart's (NASDAQ:VXRT) shares rose following the positive results from an early-stage trial of its new oral pill vaccine for norovirus, a more advanced version compared to its first-generation ...

Lancet Infect Diseases, Vol 25. Issue 5, 519-536 Lopman BA et al. The vast and varied global burden of norovirus: prospects for prevention and control. PLOS medicine 2016 13 (4): e1001999.

Vaxart, Inc., a biotechnology company focused on oral recombinant pill vaccines, announced it will release topline data from its Phase I trial on norovirus before the market opens on June 11, 2025.